Chemical Compound Review:
GNF-PF-1199 2-phenylethanamide
Synonyms:
PubChem13418, CPD-238, SureCN25676, AGN-PC-0D9X2J, CHEMBL347645, ...
- Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury. Hall, E.D., Wolf, D.L., Althaus, J.S., Von Voigtlander, P.F. Brain Res. (1987)
- Adaptation to phenylacetamide as a growth substrate by an acetanilide-utilizing mutant of Pseudomonas aeruginosa. Gregoriou, M., Brown, P.R. Arch. Microbiol. (1980)
- Atenolol developmental toxicity: animal-to-human comparisons. Tabacova, S., Kimmel, C.A., Wall, K., Hansen, D. Birth defects research. Part A, Clinical and molecular teratology. (2003)
- Mu opioid transactivation and down-regulation of the epidermal growth factor receptor in astrocytes: implications for mitogen-activated protein kinase signaling. Belcheva, M.M., Tan, Y., Heaton, V.M., Clark, A.L., Coscia, C.J. Mol. Pharmacol. (2003)
- Ligand-induced conformational change in penicillin acylase. Done, S.H., Brannigan, J.A., Moody, P.C., Hubbard, R.E. J. Mol. Biol. (1998)
- Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes. Stiene-Martin, A., Zhou, R., Hauser, K.F. Glia (1998)
- Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands. Huang, Y., Hammond, P.S., Whirrett, B.R., Kuhner, R.J., Wu, L., Childers, S.R., Mach, R.H. J. Med. Chem. (1998)
- Differential agonist regulation of the human kappa-opioid receptor. Blake, A.D., Bot, G., Li, S., Freeman, J.C., Reisine, T. J. Neurochem. (1997)
- Selective and enantiospecific acylation of kappa opioid receptors by (1S,2S)-trans-2-isothiocyanato-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexy l] benzeneacetamide. Demonstration of kappa receptor heterogeneity. de Costa, B.R., Rothman, R.B., Bykov, V., Jacobson, A.E., Rice, K.C. J. Med. Chem. (1989)
- Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals. Vaupel, D.B., Cone, E.J., Johnson, R.E., Su, T.P. J. Pharmacol. Exp. Ther. (1990)
- Enantioselective kappa opioid binding sites on the macrophage cell line, P388d1. Carr, D.J., DeCosta, B.R., Jacobson, A.E., Rice, K.C., Blalock, J.E. Life Sci. (1991)
- Opioid receptors mediate a postsynaptic facilitation and a presynaptic inhibition at the afferent synapse of axolotl vestibular hair cells. Vega, R., Soto, E. Neuroscience (2003)
- Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors. Utz, J., Eckert, R., Trautwein, W. J. Pharmacol. Exp. Ther. (1995)
- Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats. McDonald, C.E., Gagnon, M.J., Ellenberger, E.A., Hodges, B.L., Ream, J.K., Tousman, S.A., Quock, R.M. J. Pharmacol. Exp. Ther. (1994)
- Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. Devine, D.P., Leone, P., Pocock, D., Wise, R.A. J. Pharmacol. Exp. Ther. (1993)
- U-50,488 blocks the development of morphine tolerance and dependence at a very low dose in guinea pigs. Tao, P.L., Hwang, C.L., Chen, C.Y. Eur. J. Pharmacol. (1994)
- Amide utilization in Aspergillus nidulans: evidence for a third amidase enzyme. Hynes, M.J. J. Gen. Microbiol. (1975)
- The kappa-opioid receptor agonist, U50,488H, exerts antidystonic activity in a mutant hamster model of generalized dystonia. Richter, A., Löscher, W. Eur. J. Pharmacol. (1993)
- Substitutions of Thr-103-Ile and Trp-138-Gly in amidase from Pseudomonas aeruginosa are responsible for altered kinetic properties and enzyme instability. Karmali, A., Pacheco, R., Tata, R., Brown, P. Mol. Biotechnol. (2001)